Lielbritānija - angļu - myHealthbox

novartis vaccines and diagnostics - neisseria meningitidis group c (strain c11) oligosaccharide, corynebacterium diphtheriae crm197 protein , adsorbed on aluminium - suspension for injection - 10micrograms, 12.5 to 25.0micrograms, 0.3 to 0.4mg al 3+ - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

gsk vaccines s.r.l. - meningococcal group c oligosaccharide; corynebacterium diphtheriae crm197 protein - suspension for injection - 10 - meningococcal vaccines; other meningococcal polyvalent purified polysaccharides antigen

Eiropas Savienība - angļu - EMA (European Medicines Agency)

gsk vaccines s.r.l. - outer membrane vesicles from neisseria meningitidis group b (strain nz 98/254), recombinant neisseria meningitidis group b fhbp fusion protein, recombinant neisseria meningitidis group b nada protein, recombinant neisseria meningitidis group b nhba fusion protein - meningitis, meningococcal - meningococcal vaccines - active immunisation against invasive disease caused by neisseria meningitidis serogroup-b strains.,

Eiropas Savienība - angļu - EMA (European Medicines Agency)

gsk vaccines s.r.l. - meningococcal group a, c, w-135 and y conjugate vaccine - immunization, meningitis, meningococcal - bacterial vaccines - prefilled syringe menveo is indicated for active immunisation of adolescents (from 11 years of age) and adults at risk of exposure to neisseria meningitidis groups a, c, w135 and y, to prevent invasive disease. the use of this vaccine should be in accordance with official recommendations. vials menveo is indicated for active immunisation of children (from two years of age), adolescents and adults at risk of exposure to neisseria meningitidis groups a, c, w135 and y, to prevent invasive disease. the use of this vaccine should be in accordance with official recommendations.,

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - meningococcal group a oligosaccharide; meningococcal group y oligosaccharide; meningococcal group w135 oligosaccharide; meningococcal group c oligosaccharide - powder and solvent for solution for injection

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

glaxosmithkline uk ltd - outer membrane vesicles (omv) from neisseria meningitidis group b containing the pora p1.4; neisseria meningitidis group b nhba fusion protein; neisseria meningitidis group b nada protein; neisseria meningitidis group b fhbp fusion protein - suspension for injection

Malaizija - angļu - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

glaxosmithkline pharmaceutical sdn. bhd. - meningococcal group c oligosaccharide; meningococcal group w oligosaccharide; meningococcal group y oligosaccharide; meningococcal group a oligosaccharide -

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

porto pavino llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antimicrobial hand sanitizer to help reduce bacteria on the skin. stop use and ask a doctor if irritation or rash and lasts.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

porto pavino llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antimicrobial hand sanitizer to help reduce bacteria on the skin. stop use and ask a doctor if irritation or rash and lasts.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

epoch cosmetics and toiletries industries llc - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - antimicrobial hand sanitizer to help reduce bacteria on the skin. stop use and ask a doctor if irritation or rash and lasts.